InfoWerks will lead a project aimed at streamlining data
exchange for the FDA's Risk Evaluation and Mitigation Strategy
(REMS) plan. Supported with a $190,000 NCPDP Foundation grant, the project will
rely on the REMS transaction within the NCPDP SCRIPT standard. It
aims to show how the standard can significantly enhance patient
safety and ease administrative burdens by reducing manual
processing delays.
SCOTTSDALE, Ariz., April 19,
2024 /PRNewswire-PRWeb/ -- Getting specialty
medications into the hands of those who need them quickly and
safely is the goal of the latest project to receive funding from
the NCPDP Foundation. InfoWerks—a leading provider of
healthcare data management solutions—will spearhead the project,
which aims to streamline data exchange for the FDA's Risk
Evaluation and Mitigation Strategy (REMS) plan.
The use of the NCPDP SCRIPT standard in this project will ensure
data is accurate, consistent, and secure, which is fundamental to
patient safety when dealing with high-risk medications and emerging
therapies.
The REMS plan, created by the FDA, aims to ensure the benefits
for patients outweigh the risks on certain specialty products and
medications. It often requires additional safety measures be taken
by stakeholders. Today, information exchanges to support REMS are
primarily manual and are not well-integrated into healthcare
systems and pharmacy workflows.
"InfoWerks has stepped up to the plate to fill a need, and the
Foundation is thrilled to support their work and the increased
uptake of this innovative, interoperable solution," said J.W. Hill,
MBAHCM, CNED, Executive Director of the NCPDP Foundation. "There is
great potential on the table to reduce the burden current REMS
processes place on healthcare institutions, patients, pharmacists,
and providers by using the NCPDP's SCRIPT standard, which has
already been updated to support REMS transactions."
Jeff Deitch, Chief Executive
Officer at InfoWerks, shared, "Receiving the grant from the NCPDP
Foundation is exciting to say the least. This opportunity propels
us toward our goal of enhancing patient safety by streamlining the
REMS process. With this support, we can empower patients and
pharmacists alike, ensuring timely access to accurate data and
promoting informed medication management."
"The grant from the NCPDP Foundation is a game-changer for our
project," added Kelee Petzelt, an
industry consultant who will manage all testing and development
throughout the project. "It's not just about simplifying the REMS
process; it's about revolutionizing the role of pharmacists in
patient care. With real-time adjudication and streamlined
workflows, we can elevate pharmacists to key stakeholders in
ensuring the safe use of high-risk medications."
The project will build a pharmacy management system and name a
technology vendor and a REMS administrator. This means REMS
programs will be much easier for pharmacies to launch. Patients
will be better informed, more closely monitored, and empowered to
manage their medications safely. Providers and pharmacies will be
better equipped to guide patients through the adoption of
innovative or complex new treatments, which are becoming more
common as the population ages.
This grant was made possible with support from the FDB Patient
Safety Founder's Donor Fund, the GoodRx Access to Care Founder's
Donor Fund, and the NCPDP Foundation General Grant Fund. The work aligns with three of the
NCPDP Foundation's strategic initiatives: increasing patient access
to care, expanding the role and value of pharmacists, and enhancing
patient safety.
"GoodRx is pleased to support the InfoWerks initiative seeking
to improve the REMS process by leveraging the REMS transactions
within the NCPDP SCRIPT to streamline data exchange. The outcome of
this program has the potential to significantly reduce
administrative burden on pharmacists, resulting in patients gaining
more timely and transparent access to their prescribed
medications," shared GoodRx Executive Medical Director Preeti Parikh, MD.
"We are proud to support InfoWerks' proposal to streamline and
improve the REMS process," added FDB President Bob Katter. "Our collaboration with these
initiatives and the NCPDP Foundation underscores our dedication to
optimizing medication decision support by streamlining complex
processes—from addressing critical issues like public health
emergencies to delays in high-risk medication drug therapy. By
integrating standards-based data exchange into healthcare workflows
and clinical decision-making, we anticipate significant
improvements in patient care and emerging therapy management."
About the NCPDP Foundation
As the grant-giving arm of the National Council for Prescription
Drug Programs (NCPDP), the NCPDP Foundation collaborates with
organizations and individuals to support research initiatives that
improve data sharing throughout the healthcare ecosystem, removing
obstacles to quality care for patients. The NCPDP Foundation is a
501(c)(3) nonprofit charitable organization headquartered in
Scottsdale, Arizona.
Media Contact
Janet Cabibbo, NCPDP Foundation,
480-477-1000 x104, jcabibbo@ncpdp.org, www.NCPDPFoundation.org
Maggie Bruce, NCPDP Foundation,
480-477-1000 x144, mbruce@ncpdp.org, www.NCPDPFoundation.org
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/ncpdp-foundation-funds-new-project-to-streamline-rems-process-for-the-industry-302120587.html
SOURCE NCPDP Foundation